These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16335261)

  • 21. Medical Treatment of Acromegaly with Dopamine Agonists or Somatostatin Analogs.
    Chanson P
    Neuroendocrinology; 2016; 103(1):50-8. PubMed ID: 25677539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newer options in the management of acromegaly.
    Burt MG; Ho KK
    Intern Med J; 2006 Jul; 36(7):437-44. PubMed ID: 16780450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The place of medical treatment of acromegaly: current status and perspectives.
    Jallad RS; Bronstein MD
    Expert Opin Pharmacother; 2013 Jun; 14(8):1001-15. PubMed ID: 23600991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of efficacy and tolerability of somatostatin analogs and other therapies for acromegaly.
    Burt MG; Ho KK
    Endocrine; 2003 Apr; 20(3):299-305. PubMed ID: 12721511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly.
    Melmed S; Sternberg R; Cook D; Klibanski A; Chanson P; Bonert V; Vance ML; Rhew D; Kleinberg D; Barkan A
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4405-10. PubMed ID: 15827109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological options in the treatment of acromegaly.
    Ezzat S
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1023-7. PubMed ID: 16259223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological therapy for acromegaly: a critical review.
    Muller AF; Van Der Lely AJ
    Drugs; 2004; 64(16):1817-38. PubMed ID: 15301564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm.
    Clemmons DR; Chihara K; Freda PU; Ho KK; Klibanski A; Melmed S; Shalet SM; Strasburger CJ; Trainer PJ; Thorner MO
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4759-67. PubMed ID: 14557452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current therapy for acromegaly.
    Stewart PM
    Trends Endocrinol Metab; 2000; 11(4):128-32. PubMed ID: 10754533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
    Bastemir M; Akin F; Yaylali GF
    Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world value of cabergoline in the treatment of acromegaly.
    Shimon I
    Best Pract Res Clin Endocrinol Metab; 2024 Jul; 38(4):101887. PubMed ID: 38443225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical management of growth hormone-secreting pituitary adenomas.
    Racine MS; Barkan AL
    Pituitary; 2002; 5(2):67-76. PubMed ID: 12675503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of acromegaly: is there a role for primary medical therapy?
    Bush ZM; Vance ML
    Rev Endocr Metab Disord; 2008 Mar; 9(1):83-94. PubMed ID: 18163213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current thinking on the management of the acromegalic patient.
    Katznelson L
    Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):311-6. PubMed ID: 17940458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacological treatment of acromegaly].
    Mercado M; Galeana M
    Gac Med Mex; 2006; 142(4):327-31. PubMed ID: 17022308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of acromegaly in Aarhus University Hospital. A retrospective investigation of the period from 1994 to 2004].
    Madsen M; Matthiesen EB; Poulsen PL; Weeke J; Astrup J; Jørgensen JO
    Ugeskr Laeger; 2007 Mar; 169(10):907-10. PubMed ID: 17359734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acromegaly: new principles for treatment].
    Jørgensen JO; Feldt-Rasmussen UF; Andersen M; Kristensen LØ; Laurberg P; Weeke J
    Ugeskr Laeger; 2007 Mar; 169(10):904-6. PubMed ID: 17359733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acromegaly: multifaceted clinical presentation of a rare disease of the elderly. Report of two cases with long-term follow-up].
    Foppiani L; Del Monte P; Ruelle A; Marugo A; Bernasconi D
    Recenti Prog Med; 2006 Apr; 97(4):200-4. PubMed ID: 16729489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth-hormone and prolactin excess.
    Colao A; Lombardi G
    Lancet; 1998 Oct; 352(9138):1455-61. PubMed ID: 9808008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acromegaly.
    Holdaway IM
    Horm Res; 2004; 62 Suppl 3():79-92. PubMed ID: 15539805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.